What is Climb Bio, Inc.'s price / book?

Climb Bio, Inc. (CLYM) reported price / book of 2.2× in Q1 2026.

How has Climb Bio, Inc.'s price / book changed year-over-year?

Climb Bio, Inc.'s price / book increased by 419.1% year-over-year, from 0.4× to 2.2×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Climb Bio, Inc. CLYM Price / book

Price / book at other companies

Bristol-Myers SquibbBMY

6.2×-1.0×

AmgenAMGN

20.6×-6.3×

Vera TherapeuticsVERA

5.7×+2.9×

Kyverna Therapeutics, Inc.KYTX

2.7×+2.3×

Cullinan Therapeutics, Inc.CGEM

1.5×+0.3×

Jade Biosciences, Inc. Common StockJBIO

2.3×—

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

CapEx$109.0K—

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Calculated from Climb Bio, Inc.’s reported figures.

market cap/total stockholders equity=2.2×

Based on the most recent quarter.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s price / book?: Climb Bio, Inc. (CLYM) reported price / book of 2.2× in Q1 2026.
How has Climb Bio, Inc.'s price / book changed year-over-year?: Climb Bio, Inc.'s price / book increased by 419.1% year-over-year, from 0.4× to 2.2×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.